We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 42,762

ALJ Emphasizes Importance of Procedural Schedule
  • Jones Day
  • USA
  • January 19 2018

In a recent order, Administrative Law Judge Bullock granted Respondents Fujifilm Holdings Corporation, Fujifilm Corporation, Fujifilm Holdings America


SPCs: where are we and where are we going?
  • Taylor Wessing
  • United Kingdom, European Union
  • January 18 2018

In this webinar, Simon Cohen, Judith Krens and Paul England, discuss the key and current supplementary protection certificate (SPC) cases currently


Common issues of direct patent infringement: 4 - infringing by repair?
  • Taylor Wessing
  • United Kingdom
  • January 18 2018

There are a number of issues of direct patent infringement that frequently arise in the area of pharmaceuticals, biologics and medical devices. The


Licence held to be exclusive despite option
  • Taylor Wessing
  • United Kingdom
  • January 18 2018

In Oxford Nanopore Technologies & Anor v Pacific Biosciences of California, Inc & Anor 2017 EWHC 3190 (Pat), the Court held that if a licence


Broadcom pitches royalty rate cuts to Chinese OEMs, but some remain sceptical of Qualcomm takeover
  • IAM
  • Global
  • January 18 2018

When Broadcom first went public with its audacious plan to buy-out Qualcomm, Microsoft and Google were reportedly among the first tech titans to


How Much Is That Issue Fee Payment In The Window?
  • Foley & Lardner LLP
  • USA
  • January 18 2018

A new USPTO fee schedule took effect on January 16, 2018, which usually means that all fees must be paid at the new (higher) rate. However, thanks to


Generic drugs taking hold in the Asian marketplace: STAT News interview
  • Hogan Lovells
  • Japan
  • January 18 2018

Aging populations and rising healthcare costs across Asia particularly in Japan have created new market opportunities for generic drug makers


Italy ready to ratify the UPC Protocol on Privileges and Immunities
  • Bristows
  • Italy
  • January 18 2018

Law 4 December 2017, n. 201, which authorises Italy’s President to ratify the Protocol on Privileges and Immunities (PPI) of the Unified Patent Court


Planned Clinical Trial for Aflibercept Signals Likely Future Contests Over Regeneron’s Eylea
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • January 18 2018

On January 3, 2018, Momenta and Mylan announced their development plan for a proposed biosimilar to Regeneron’s Eylea whose active ingredient is


Trump threatens IP fine for China, while SCOTUS could help patent owners get tough on overseas infringement
  • IAM
  • USA, China
  • January 18 2018

In an interview earlier this week President Trump announced that his administration is preparing to get tough on Chinese trade practices and accused